Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Lab Automation is a multi-disciplinary approach to develop and optimize on technologies in the laboratory, in order to improve the medical tests and processes. It has replaced the manual steps with automated processes, which were potentially dangerous and error-prone.
The global lab automation market is estimated to account for US$ 4,477.0 Mn in terms of value in 2020 and is expected to reach US$ 6,262.3 Mn by the end of 2027.
Global Lab Automation Market: Drivers
Increasing demand for lab automation in the pharmaceutical and biotechnology sector is expected to propel growth of the global lab automation market over the forecast period. Lab automation utilizes high end automated equipment such as automated liquid handling system, microplate reader, and automated storage and retrieval system. It also include software to perform variety of routine lab procedure such as sample analysis, assay performance, mixing of sample, storage of sample, and many other procedures. Lab automation allows improved productivity with less operational time and more accuracy by minimizing the human error in the operational tasks. Automated liquid handling system can perform three different procedures simultaneously such as sample preparation, reagent addition to different plates having samples, and movement of lab ware from periphery to front area of desk.
Moreover, increasing prevalence of chronic diseases is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Liquid handling products held dominant position in the global lab automation market in 2019, accounting for 40.3% share in terms of value, followed by Microplate reader and Robotics and Others, respectively.
Figure 1. Global Lab Automation Market Share (%), by Value, by Product, 2019
Global Lab Automation Market: Restraints
High cost of automation is expected to hinder growth of the global lab automation market. The high cost of automation is one of the objections that each laboratory faces. The higher investment resists the laboratories to buy the product. Moreover, the need to expand or remodel the laboratory’s workspace serves as a barrier in implementation of the lab automation, as it serves as an extra burden on the costing.
Moreover, low adoption of lab automation in emerging economies is also expected to limit the market growth.
Lab Automation Market Report Coverage
||Market Size in 2019:
||US$ 4,268.9 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 6,262.3 Mn
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: South Africa, North Africa, Central Africa
- By Product: Liquid Handling Products, Microplate reader, Robotics and Others.
- By End User: Research Institutes, Biopharmaceuticals and pharmaceuticals, Others.
Tecan Group Ltd., PerkinElmer Inc., Danaher Corporation, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Hamilton Company, COPAN Diagnostics, Inc., Abbot Diagnostics, Eppendorf, Roche Diagnostics, Siemens Healthineers, UiPath, and Porvair Sciences.
- Technological advancement
- Increasing demand from pharmaceutical and biotechnology industry
|Restraints & Challenges:
Global Lab Automation Market: Opportunities
Growing pharmaceutical sector is expected to offer lucrative growth opportunities for players in the global lab automation market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018.
Increasing number of labs conducting testing for COVID-19 is also expected to boost demand for lab automation. For instance, in February 2020, the U.S. Food and Drug Administration (FDA) expanded its Emergency Use Authorization (EUA) policy to allow more labs to apply for approval to conduct testing for COVID-19.
The global lab automation market was valued at US$ 4,268.9 Mn in 2019 and is forecast to reach a value of US$ 6,262.3 Mn by 2027 at a CAGR of 4.9% between 2020 and 2027.
Figure 2. Global Lab Automation Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027
Market Trends/Key Takeaways
Increasing number of clinical trials is expected to propel growth of the global lab automation market. For instance, according to the U.S. National Library of Medicine, the number of clinical trials conducted in the U.S. increased from 30,978 in 2018 to 32,523 in 2019.
Moreover, development and launch of novel lab automation solutions is also expected to aid in growth of the market. For instance, in January 2018, Hamilton Company developed a method for automating the library preparation of SOPHiA GENETICS’ CE-IVD marked hereditary cancer solution application in an advanced and flexible way through microlet automated workflow system.
Global Lab Automation Market: Competitive Landscape
Major players operating in the global lab automation market include, Tecan Group Ltd., PerkinElmer Inc., Danaher Corporation, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Hamilton Company, COPAN Diagnostics, Inc., Abbot Diagnostics, Eppendorf, Roche Diagnostics, Siemens Healthineers, UiPath, and Porvair Sciences.
Global Lab Automation Market: Key Developments
Major players in the market are focused on launching new products to expand their product portfolio For instance, in July 2020, Porvair Sciences, a manufacturer of microplates & microplate instruments, launched a new range of low-profile deep well microplates - optimized for laboratory automation.
Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in April 2020, Hamilton Company and Integrated Micro-Chromatography Systems launched the affinityPure STAR assay ready workstation as part of their ongoing collaboration.